Claraphi Advisory Network’s Exact Sciences EXAS Stock Holding History

Claraphi Advisory Network’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,094	Closed	-$260K	–	322
2021 Q2	$260K	Sell	2,094 -2,183	-51%	-$261K	0.08%	268
2021 Q1	$564K	Buy	+4,277	New	+$585K	0.16%	141
2020 Q2	–	Sell	-1,390	Closed	-$81K	–	554
2020 Q1	$81K	Buy	+1,390	New	+$113K	0.04%	379

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Claraphi Advisory Network's EXAS Position: Q3 2021 in Review

Claraphi Advisory Network sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 2,094 shares — an estimated $260K sold.

Claraphi Advisory Network first reported a position in EXAS in Q1 2020 and held it in 3 quarters. The position peaked at $564K in Q1 2021. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

Claraphi Advisory Network reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
Claraphi Advisory Network sold 2,094 Exact Sciences shares in Q3 2021, an estimated $260K.
Claraphi Advisory Network first reported a position in Exact Sciences in Q1 2020 and held it in 3 quarters.
Claraphi Advisory Network's Exact Sciences position peaked at $564K in Q1 2021.
602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Claraphi Advisory Network's 13F filing for Q3 2021, filed 15 Nov 2021.